<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: antibody responses</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Vaccine blackjack: IL-21 critical to fight against viral infections</title>
   	 <description>(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.</description>
     <link>http://medicalxpress.com/news/2013-05-vaccine-blackjack-il-critical-viral.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 23 May 2013 07:46:40 EST</pubDate>
	 <guid isPermaLink="false">news288513993</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/vaccineblack.jpg" width="90" height="90" />
</item>
<item>
     <title>Succesful results in developing oral vaccine against diarrhea</title>
   	 <description>The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.</description>
     <link>http://medicalxpress.com/news/2013-05-succesful-results-oral-vaccine-diarrhea.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 22 May 2013 08:20:02 EST</pubDate>
	 <guid isPermaLink="false">news288427521</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/succesfulres.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers find potential map to more effective HIV vaccine</title>
   	 <description>By tracking the very earliest days of one person's robust immune response to HIV, researchers have charted a new route for developing a long-sought vaccine that could boost the body's ability to neutralize the virus.</description>
     <link>http://medicalxpress.com/news/2013-04-potential-effective-hiv-vaccine.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 03 Apr 2013 13:16:45 EST</pubDate>
	 <guid isPermaLink="false">news284213799</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/4-3-2-1-researchersf.jpg" width="90" height="90" />
</item>
<item>
     <title>Investigational vaccine not effective in reducing post-operative staph infections</title>
   	 <description>Use of a vaccine to prevent Staphylococcus aureus infections among patients undergoing cardiothoracic surgery did not reduce the rate of serious postoperative S aureus infections compared with placebo and was associated with increased mortality among patients who developed S aureus infections, according to a study in the April 3 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2013-04-vaccine-effective-post-operative-staph-infections.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 02 Apr 2013 16:00:07 EST</pubDate>
	 <guid isPermaLink="false">news284126075</guid>
	 
</item>
<item>
     <title>New vaccine-design approach targets HIV and other fast-mutating viruses</title>
   	 <description>A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.</description>
     <link>http://medicalxpress.com/news/2013-03-vaccine-design-approach-hiv-fast-mutating-viruses.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 28 Mar 2013 14:29:32 EST</pubDate>
	 <guid isPermaLink="false">news283699766</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/newvaccinede.jpg" width="90" height="90" />
</item>
<item>
     <title>Research reveals protective properties of influenza vaccines</title>
   	 <description>(Medical Xpress)—Collaborating scientists from Nationwide Children's Hospital, Baylor Institute for Immunology Research, and Mount Sinai School of Medicine have identified an important mechanism for stimulating protective immune responses following seasonal influenza vaccinations. The study was published in Science Translational Medicine, a journal of the American Association for the Advancement of Science (AAAS).</description>
     <link>http://medicalxpress.com/news/2013-03-reveals-properties-influenza-vaccines.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 25 Mar 2013 09:02:38 EST</pubDate>
	 <guid isPermaLink="false">news283420946</guid>
	 
</item>
<item>
     <title>Two-pronged immune cell approach could lead to universal shot against flu</title>
   	 <description>Seasonal epidemics of influenza result in nearly 36,000 deaths annually in the United States, according to the Centers for Disease Control. Current vaccines against the influenza virus elicit an antibody response specific for proteins on the outside of the virus, specifically the hemagglutinin (HA) protein.</description>
     <link>http://medicalxpress.com/news/2013-03-two-pronged-immune-cell-approach-universal.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 14 Mar 2013 17:00:05 EST</pubDate>
	 <guid isPermaLink="false">news282498498</guid>
	 
</item>
<item>
     <title>Progesterone may be why pregnant women are more vulnerable to certain infections</title>
   	 <description>Women who are pregnant or using synthetic progesterone birth control injections have a conspicuous vulnerability to certain infections including malaria, Listeria, HIV, and herpes simplex virus. A new research report appearing in the March 2013 issue of the Journal of Leukocyte Biology offers strong evidence for a possible explanation: the progesterone receptor, a pregnancy hormone sensor, targets a part of the immune system responsible for protection against these and other invaders. In addition to helping explain why some women are more vulnerable to certain infections, it also sheds light on why some autoimmune diseases, notably rheumatoid arthritis and multiple sclerosis, often go into remission during pregnancy.</description>
     <link>http://medicalxpress.com/news/2013-02-progesterone-pregnant-women-vulnerable-infections.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 28 Feb 2013 11:11:23 EST</pubDate>
	 <guid isPermaLink="false">news281272260</guid>
	 
</item>
<item>
     <title>Association found between length of biological marker and development of respiratory infection</title>
   	 <description>Among healthy adults who were administered a cold virus, those with shorter telomere length (a structure at the end of a chromosome) in certain cells were more likely to develop experimentally-induced upper respiratory infection than participants with longer telomeres, according to results of preliminary research published in the February 20 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2013-02-association-length-biological-marker-respiratory.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 19 Feb 2013 17:20:02 EST</pubDate>
	 <guid isPermaLink="false">news280514010</guid>
	 
</item>
<item>
     <title>New insights into HIV vaccine will improve drug development</title>
   	 <description>Four years ago, a potential HIV vaccine showed promise against the virus that causes AIDS, but it fell short of providing the broad protection necessary to stem the spread of disease.</description>
     <link>http://medicalxpress.com/news/2013-01-insights-hiv-vaccine-drug.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 10 Jan 2013 12:00:04 EST</pubDate>
	 <guid isPermaLink="false">news277027034</guid>
	 
</item>
<item>
     <title>Ebola virus uses a protein decoy to subvert the host immune response</title>
   	 <description>In a study published today in the Open Access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its infected host.</description>
     <link>http://medicalxpress.com/news/2012-12-ebola-virus-protein-decoy-subvert.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 13 Dec 2012 17:23:30 EST</pubDate>
	 <guid isPermaLink="false">news274641804</guid>
	 
</item>
<item>
     <title>New research helps predict susceptibility to Burkitt lymphoma</title>
   	 <description>New research, presented this morning at the 54th Annual Meeting of the American Society of Hematology (ASH), has identified important associations between Plasmodium falciparum (Pf) malaria and endemic Burkitt Lymphoma (eBL) that may help researchers identify young children who are more susceptible to eBL.</description>
     <link>http://medicalxpress.com/news/2012-12-susceptibility-burkitt-lymphoma.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 11 Dec 2012 14:54:08 EST</pubDate>
	 <guid isPermaLink="false">news274459994</guid>
	 
</item>
<item>
     <title>Positive early results in clinical trial of leukaemia vaccine</title>
   	 <description>Early results of a trial to treat leukaemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date.</description>
     <link>http://medicalxpress.com/news/2012-12-positive-early-results-clinical-trial.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 07 Dec 2012 11:50:06 EST</pubDate>
	 <guid isPermaLink="false">news274100504</guid>
	 
</item>
<item>
     <title>Researchers discover how the deadly malaria parasite evades the immune system, make progress toward developing a cure</title>
   	 <description>(Medical Xpress)—More than a million people die each year of malaria caused by different strains of the Plasmodium parasite transmitted by the Anopheles mosquito. The medical world has yet to find an effective vaccine against the deadly parasite, which mainly affects pregnant women and children under the age of five. By figuring out how the most dangerous strain evades the watchful eye of the immune system, researchers from the Hebrew University of Jerusalem have now paved the way for the development of new approaches to cure this acute infection.</description>
     <link>http://medicalxpress.com/news/2012-12-deadly-malaria-parasite-evades-immune.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 03 Dec 2012 08:58:30 EST</pubDate>
	 <guid isPermaLink="false">news273747380</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/102-researchersd.jpg" width="90" height="90" />
</item>
<item>
     <title>Dispelling common myths about the flu vaccine</title>
   	 <description>Every fall, people wonder whether to get an influenza or flu shot.</description>
     <link>http://medicalxpress.com/news/2012-11-dispelling-common-myths-flu-vaccine.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 29 Nov 2012 07:06:06 EST</pubDate>
	 <guid isPermaLink="false">news273395139</guid>
	 
</item>
<item>
     <title>How defects in a signaling protein sabotage the immune system in multiple, seemingly contradictory ways</title>
   	 <description>The antibody response to immune threats is managed by cells known as B lymphocytes. The differentiation and function of B cells are tightly regulated to ensure a prompt response to confirmed dangers, such as viruses or bacteria, and also to prevent the emergence of harmful autoimmune responses that can damage healthy tissues in the body.</description>
     <link>http://medicalxpress.com/news/2012-11-defects-protein-sabotage-immune-multiple.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 21 Nov 2012 07:22:56 EST</pubDate>
	 <guid isPermaLink="false">news272704962</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-immunologyma.jpg" width="90" height="90" />
</item>
<item>
     <title>Meth vaccine shows promising results in early tests</title>
   	 <description>Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of meth intoxication. If the vaccine proves effective in humans too, it could become the first specific treatment for meth addiction, which is estimated to affect 25 million people worldwide.</description>
     <link>http://medicalxpress.com/news/2012-11-meth-vaccine-results-early.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Thu, 01 Nov 2012 09:25:34 EST</pubDate>
	 <guid isPermaLink="false">news270980723</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/methvaccines.jpg" width="90" height="90" />
</item>
<item>
     <title>Study discovers unique feature of HIV that helps to create antibodies</title>
   	 <description>Wits researchers have played a pivotal role in an AIDS study published today in the journal, Nature Medicine, which describes how a unique change in the outer covering of the virus found in two HIV infected South African women enabled them to make potent antibodies which are able to kill up to 88% of HIV types from around the world.</description>
     <link>http://medicalxpress.com/news/2012-10-unique-feature-hiv-antibodies.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 22 Oct 2012 09:25:42 EST</pubDate>
	 <guid isPermaLink="false">news270116729</guid>
	 
</item>
<item>
     <title>'Original antigenic sin' at the center of researchers' model addressing age-specific influenza immunity</title>
   	 <description>(Medical Xpress)—Mathematicians are helping to build a better picture of how populations develop immunity to flu and which groups are most at risk of getting – and transmitting – infection each year.</description>
     <link>http://medicalxpress.com/news/2012-10-antigenic-center-age-specific-influenza-immunity.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 11 Oct 2012 06:55:03 EST</pubDate>
	 <guid isPermaLink="false">news269157294</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/originalsina.jpg" width="90" height="90" />
</item>
<item>
     <title>Blood markers reveal severity of common kidney disease</title>
   	 <description>Increasing blood levels of particular proteins may act as warning signs for patients with one of the most common diseases of the kidney, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings could lead to better diagnosis and management of patients with the disease, called IgA nephropathy.</description>
     <link>http://medicalxpress.com/news/2012-08-blood-markers-reveal-severity-common.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 16 Aug 2012 17:00:04 EST</pubDate>
	 <guid isPermaLink="false">news264345347</guid>
	 
</item>
<item>
     <title>Improving human immunity to malaria</title>
   	 <description>The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells. </description>
     <link>http://medicalxpress.com/news/2012-08-human-immunity-malaria.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 01 Aug 2012 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news263039631</guid>
	 
</item>
<item>
     <title>Clinical trial of human hookworm vaccine begins at Children's National Medical Center</title>
   	 <description>Today, the Sabin Vaccine Institute, in partnership with the George Washington University and the Children's National Medical Center, began vaccinating participants for a Phase 1 clinical trial of a novel human hookworm vaccine. The trial will investigate the Na-GST-1 antigen developed by the Sabin Vaccine Institute Product Development Partnership (Sabin PDP) to prevent hookworm infections in endemic areas.</description>
     <link>http://medicalxpress.com/news/2012-06-clinical-trial-human-hookworm-vaccine.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 13 Jun 2012 10:50:25 EST</pubDate>
	 <guid isPermaLink="false">news258803411</guid>
	 
</item>
<item>
     <title>HIV 'superinfection' boosts immune response</title>
   	 <description>Women who have been infected by two different strains of HIV from two different sexual partners &amp;#150; a condition known as HIV superinfection &amp;#150; have more potent antibody responses that block the replication of the virus compared to women who've only been infected once. These findings, by researchers at Fred Hutchinson Cancer Research Center in Seattle, are published online March 29 in PLoS Pathogens.</description>
     <link>http://medicalxpress.com/news/2012-03-hiv-superinfection-boosts-immune-response.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 29 Mar 2012 17:28:39 EST</pubDate>
	 <guid isPermaLink="false">news252260908</guid>
	 
</item>
<item>
     <title>PFCs, chemicals in environment, linked to lowered immune response to childhood vaccinations</title>
   	 <description>A new study finds that perfluorinated compounds (PFCs), widely used in manufactured products such as non-stick cookware, waterproof clothing, and fast-food packaging, were associated with lowered immune response to vaccinations in children. It is the first study to document how PFCs, which can be transferred to children prenatally (via the mother) and postnatally from exposure in the environment, can adversely affect vaccine response.</description>
     <link>http://medicalxpress.com/news/2012-01-pfcs-chemicals-environment-linked-lowered.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 24 Jan 2012 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news246642813</guid>
	 
</item>
<item>
     <title>Experimental vaccine partially protects monkeys from HIV-like infection</title>
   	 <description>Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys. In addition, in the animals that became infected, the optimal vaccine combinations also substantially reduced the amount of virus in the blood. Results from the studies were published online today in the journal Nature.</description>
     <link>http://medicalxpress.com/news/2012-01-experimental-vaccine-partially-monkeys-hiv-like.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 04 Jan 2012 13:00:03 EST</pubDate>
	 <guid isPermaLink="false">news244898042</guid>
	 
</item>
<item>
     <title>Cell membrane proteins could provide targets for broader vaccines</title>
   	 <description>Vaccines with broader reach might be made by stimulating specialized immune cells to recognize foreign cell membrane proteins that are shared across bacterial species, say researchers from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine in a report published online today in Immunity. The approach could be particularly beneficial in preventing infection by multi-drug resistant organisms.</description>
     <link>http://medicalxpress.com/news/2011-12-cell-membrane-proteins-broader-vaccines.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 22 Dec 2011 16:37:04 EST</pubDate>
	 <guid isPermaLink="false">news243794216</guid>
	 
</item>
<item>
     <title>Natural killers help fight human disease</title>
   	 <description>(Medical Xpress) -- Researchers from The Australian National University have discovered a new type of cell which boosts the human body&amp;#146;s ability to fight off infections and life-threatening diseases.</description>
     <link>http://medicalxpress.com/news/2011-11-natural-killers-human-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 28 Nov 2011 04:23:27 EST</pubDate>
	 <guid isPermaLink="false">news241676556</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/naturalkille.jpg" width="90" height="90" />
</item>
<item>
     <title>IADR/AADR publish study on dental caries vaccine</title>
   	 <description>In a report on a preclinical investigation titled &quot;Flagellin Enhances Saliva IgA Response and Protection of Anti-caries DNA Vaccine,&quot; lead author Wei Shi, Wuhan Institute of Virology, Chinese Academy of Sciences, and his team of researchers demonstrate that anti-caries DNA vaccines, including pGJA-P/VAX, are promising for preventing dental caries. However, challenges remain because of the low immunogenicity of DNA vaccines. This study is published in the Journal of Dental Research, the official publication of the International and American Associations for Dental Research (IADR/AADR).</description>
     <link>http://medicalxpress.com/news/2011-10-iadraadr-publish-dental-caries-vaccine.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 25 Oct 2011 14:39:59 EST</pubDate>
	 <guid isPermaLink="false">news238771528</guid>
	 
</item>
<item>
     <title>Researchers isolate new potent and broadly effective antibodies against HIV</title>
   	 <description>A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of 17 novel antibodies capable of neutralizing a broad spectrum of variants of HIV, the virus that causes AIDS.</description>
     <link>http://medicalxpress.com/news/2011-08-isolate-potent-broadly-effective-antibodies.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 17 Aug 2011 13:02:12 EST</pubDate>
	 <guid isPermaLink="false">news232804902</guid>
	 
</item>
<item>
     <title>Any prime-boost mix of injected or spray flu vaccine shields toddlers</title>
   	 <description>Children younger than 3 years old receive the same protective antibody response from the recommended two doses of licensed seasonal influenza vaccines regardless of whether the two doses are injected by needle, inhaled through a nasal spray or provided through one dose of each in any order, according to researchers funded by the National Institutes of Health. Doctors usually give young children two matching vaccines, and one goal of the study was to determine whether giving two different types of vaccines works just as well.</description>
     <link>http://medicalxpress.com/news/2011-08-prime-boost-flu-vaccine-shields-toddlers.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 16 Aug 2011 10:44:34 EST</pubDate>
	 <guid isPermaLink="false">news232710259</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/anyprimeboos.jpg" width="90" height="90" />
</item>


</channel>
</rss>
